scholarly journals Fetal Hydantoin Syndrome: A Case Report

1970 ◽  
Vol 30 (1) ◽  
pp. 57-59
Author(s):  
Needa Shrestha Shakya ◽  
Simmi Misra Gurubacharya ◽  
Dhana Raj Aryal

A term baby born to an epileptic mother who was treated with Phenytoin until 10weeks of pregnancy was born with multiple congenital anomalies and diagnosed to have Fetal Hydantoin Syndrome. Infants of mothers who have taken hydantoin during pregnancy have been found to have broad multisystem patterns of abnormalities, including mental retardation, craniofacial anomalies, nail and digital hypoplasia and prenatal onset of growth deficiency. The discussion aims to bring to attention the potential hazard of the use of hydantoin drug during reproductive age to all medical practitioners. Key words: Congenital anomalies, epilepsy, fetal hydantoin syndrome, phenytoin. DOI: 10.3126/jnps.v30i1.2463 Journal of Nepal Paediatric Society Vol.30(1) 2010 57-59

2020 ◽  
Vol 13 (9) ◽  
pp. e235845
Author(s):  
Isa Abdulkadir ◽  
Sani Musa ◽  
Fatima Lami Abdullahi ◽  
Laila Hassan

Congenital absence of the nasal septum (hyporhynia) is infrequently reported in the literature. We report a rare case in a newborn with multiple congenital anomalies with the aim to highlight its rarity and compatibility with life in a resource-limited setting. The case notes of the child were summarised and the relevant literature reviewed to give the report a context. A 2-hour-old term baby boy presented with a history of abnormal facie characterised by a single nostril and noisy breathing. On examination, he had stridulous breathing, bilateral proptosis, sloping of the forehead, depressed nasal bridge absent nasal septum, absence of columella and hypoplastic mid-face, among other dysmorphic features. A diagnosis of hyporhynia in a baby with multiple congenital anomalies was made and managed accordingly. The baby was discharged to continue follow-up. Congenital absence of the nasal septum is rare and could present without respiratory distress and may be compatible with life.


2000 ◽  
Vol 16 (3) ◽  
pp. 0176 ◽  
Author(s):  
M. C. Esmer ◽  
G. Rodriguez-Soto ◽  
D. Carrasco-Daza ◽  
M. L. Iracheta ◽  
V. Del Castillo

1993 ◽  
Vol 46 (4) ◽  
pp. 460-466 ◽  
Author(s):  
Muin J. Khoury ◽  
Lorenzo Botto ◽  
Grady D. Waters ◽  
Pierpaolo Mastroiacovo ◽  
Eduardo Castilla ◽  
...  

Gene ◽  
2015 ◽  
Vol 559 (1) ◽  
pp. 94-98 ◽  
Author(s):  
Sushil Kumar Jaiswal ◽  
Ashok Kumar ◽  
Akhtar Ali ◽  
Amit Kumar Rai

PEDIATRICS ◽  
1987 ◽  
Vol 80 (1) ◽  
pp. 120-120
Author(s):  
FRANZ W. ROSA ◽  
JUHANA IDANPAAN-HEIKKILA ◽  
RITA ASANTI

To the Editor.— Kaler et al (Pediatrics 1987;79:434-436) provided a case report of hypertrichosis and multiple congenital anomalies with maternal minoxidil use. Reports such as this contribute to alerting national drug safety offices of possible teratologic questions. Maternal drug exposure data, since 1979 when minoxidil was marketed, is available to the Food and Drug Administration (FDA) from 73,000 pregnancies (15,600 birth defects, 4,400 spontaneous abortions, and 53,000 normal outcomes). This yields, in addition to the report by Kaler et al, only two other births with maternal minoxidil exposures:


Sign in / Sign up

Export Citation Format

Share Document